{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-113952","form_type":"8-K","ticker":"SONX","cik":"0001407973","company_name":"Sonendo, Inc.","filed_at":"2024-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.363657+00:00","generated_at":"2026-05-30T16:30:33.304639+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sonendo prelim Q3 rev $7.9-$8.0M, raises FY2024 guidance; stalking horse bid for Biolase assets","bullets":["Total revenue expected $7.9-$8.0M; console approx $1.8M, procedural instruments approx $5.1M.","Cash, cash equivalents and short-term investments approx $17.3M at Sept 30, 2024.","Full-year 2024 revenue guidance raised to $31.5-$32.5M from prior $31.0-$32.0M.","Double-digit console backlog for third straight quarter.","Positioned as stalking horse bidder to acquire certain assets of Biolase in Chapter 11 bankruptcy."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-113952","json":"https://secwatch.observer/filing/0000950170-24-113952.json","markdown":"https://secwatch.observer/filing/0000950170-24-113952.md","text":"https://secwatch.observer/filing/0000950170-24-113952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/0000950170-24-113952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1407973/000095017024113952/sonx-20241010.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T16:30:33.304639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}